DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+21.45%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.75B
AUM Growth
+$332M
(+6.1%)
Cap. Flow
-$834M
Cap. Flow
% of AUM
-14.52%
Top 10 Holdings %
Top 10 Hldgs %
51.71%
Holding
447
New
223
Increased
65
Reduced
45
Closed
77
Top Buys
| 1 |
BioNTech
BNTX
|
$52.5M |
| 2 |
Kyverna Therapeutics
KYTX
|
$36.3M |
| 3 |
Perspective Therapeutics
CATX
|
$33.5M |
| 4 |
Larimar Therapeutics
LRMR
|
$32.6M |
| 5 |
Surgery Partners
SGRY
|
$32.3M |
Top Sells
| 1 |
Viking Therapeutics
VKTX
|
$66.9M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$64M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$62.6M |
| 4 |
Baxter International
BAX
|
$57.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
$28.4M |
Sector Composition
| 1 | Healthcare | 88.87% |
| 2 | Industrials | 0.71% |
| 3 | Technology | 0.31% |
| 4 | Consumer Discretionary | 0.26% |
| 5 | Financials | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Targa Resources
TRGP
$34.9B
| $364K | 0.01% |
+3,247
| New | +$364K |
|
202
Mativ Holdings
MATV
$680M
| $363K | 0.01% |
19,384
-4,063
| -17% | -$76.2K |
|
203
Usana Health Sciences
USNA
$581M
| $363K | 0.01% |
+7,491
| New | +$363K |
|
204
Leidos
LDOS
$23B
| $362K | 0.01% |
2,758
-1,424
| -34% | -$187K |
|
205
Ralph Lauren
RL
$18.9B
| $357K | 0.01% |
1,903
-816
| -30% | -$153K |
|
206
National Research Corp
NRC
$355M
| $356K | 0.01% |
+8,994
| New | +$356K |
|
207
CNO Financial Group
CNO
$3.85B
| $355K | 0.01% |
+12,915
| New | +$355K |
|
208
Deere & Co
DE
$128B
| $353K | 0.01% |
+860
| New | +$353K |
|
209
Palantir
PLTR
$363B
| $353K | 0.01% |
+15,350
| New | +$353K |
|
210
Teradata
TDC
$1.99B
| $352K | 0.01% |
+9,102
| New | +$352K |
|
211
B&G Foods
BGS
$374M
| $349K | 0.01% |
+30,521
| New | +$349K |
|
212
Americold
COLD
$3.98B
| $349K | 0.01% |
+13,995
| New | +$349K |
|
213
Life Time Group Holdings
LTH
$6.38B
| $349K | 0.01% |
22,462
+4,154
| +23% | +$64.5K |
|
214
AvidXchange
AVDX
$2.06B
| $346K | 0.01% |
+26,297
| New | +$346K |
|
215
ProAssurance
PRA
$1.22B
| $345K | 0.01% |
+26,865
| New | +$345K |
|
216
Akero Therapeutics
AKRO
$3.58B
| $345K | 0.01% |
+13,645
| New | +$345K |
|
217
New York Times
NYT
$9.6B
| $344K | 0.01% |
+7,964
| New | +$344K |
|
218
Immersion
IMMR
$230M
| $343K | 0.01% |
45,826
-13,249
| -22% | -$99.1K |
|
219
Columbia Sportswear
COLM
$3.09B
| $342K | 0.01% |
+4,216
| New | +$342K |
|
220
AT&T
T
$212B
| $342K | 0.01% |
+19,441
| New | +$342K |
|
221
Walmart
WMT
$801B
| $339K | 0.01% |
+5,637
| New | +$339K |
|
222
TETRA Technologies
TTI
$625M
| $338K | 0.01% |
+76,314
| New | +$338K |
|
223
AMC Networks
AMCX
$328M
| $338K | 0.01% |
+27,839
| New | +$338K |
|
224
Arcutis Biotherapeutics
ARQT
$2.06B
| $334K | 0.01% |
+33,714
| New | +$334K |
|
225
PepsiCo
PEP
$200B
| $334K | 0.01% |
+1,909
| New | +$334K |
|